EPIDERMOLYSIS BULLOSA (EB)
Clinical trials for EPIDERMOLYSIS BULLOSA (EB) explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA (EB) trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA (EB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cream trial offers hope for healing painful skin blisters in children
Disease control Not yet recruitingThis study is testing whether a daily cream called SD-101 can help heal wounds in children with epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. About 80 children, aged 1 month to 12 years, will apply the cream or a placebo to their entire body for 60…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Oxygen chamber trial tests hope for dozens of Tough-to-Treat illnesses
Disease control Not yet recruitingThis study is gathering information to see how well hyperbaric oxygen therapy (HBOT) works for over 40 different health conditions. It will enroll about 100 people who have been referred for HBOT for conditions like Long COVID, Crohn's disease, and various ulcers. The main goal i…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Year-Long skin cream safety test for fragile skin condition
Symptom relief Not yet recruitingThis study aims to check the long-term safety of a skin cream called SD-101 for people with epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. About 80 participants who completed a previous related study will apply the cream to their entire body once da…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Symptom relief
Last updated Apr 04, 2026 02:20 UTC